Tikun Olam-Cannbit Pharmaceuticals Ltd (TLV:TKUN)
39.20
+0.80 (2.08%)
Apr 28, 2025, 12:09 PM IDT
TLV:TKUN Revenue
In the year 2024, Tikun Olam-Cannbit Pharmaceuticals had annual revenue of 34.95M ILS, down -20.97%. Tikun Olam-Cannbit Pharmaceuticals had revenue of 14.10M in the half year ending December 31, 2024, a decrease of -49.90%.
Revenue
34.95M
Revenue Growth
-20.97%
P/S Ratio
0.93
Revenue / Employee
1.84M
Employees
19
Market Cap
32.63M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 34.95M | -9.28M | -20.97% |
Dec 31, 2023 | 44.23M | -5.07M | -10.28% |
Dec 31, 2022 | 49.30M | 12.27M | 33.13% |
Dec 31, 2021 | 37.03M | 15.37M | 70.97% |
Dec 31, 2020 | 21.66M | - | - |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Teva Pharmaceutical Industries | 60.26B |
Danel (Adir Yeoshua) | 2.77B |
Kamada | 586.24M |
Bait Bakfar | 103.40M |
Novolog (Pharm-Up 1966) | 2.02B |
Ilex Medical | 920.37M |
BrainsWay | 149.39M |
SofWave Medical | 217.27M |